Your browser doesn't support javascript.
loading
Body Mass Index and Risk of Colorectal Cancer Incidence and Mortality in Asia.
Paragomi, Pedram; Zhang, Zhongjie; Abe, Sarah Krull; Islam, Md Rashedul; Rahman, Md Shafiur; Saito, Eiko; Shu, Xiao-Ou; Dabo, Bashir; Pham, Yen Thi-Hai; Chen, Yu; Gao, Yu-Tang; Koh, Woon-Puay; Sawada, Norie; Malekzadeh, Reza; Sakata, Ritsu; Hozawa, Atsushi; Kim, Jeongseon; Kanemura, Seiki; Nagata, Chisato; You, San-Lin; Ito, Hidemi; Park, Sue K; Yuan, Jian-Min; Pan, Wen-Harn; Wen, Wanqing; Wang, Renwei; Cai, Hui; Tsugane, Shoichiro; Pourshams, Akram; Sugawara, Yumi; Wada, Keiko; Chen, Chien-Jen; Oze, Isao; Shin, Aesun; Ahsan, Habibul; Boffetta, Paolo; Chia, Kee Seng; Matsuo, Keitaro; Qiao, You-Lin; Rothman, Nathaniel; Zheng, Wei; Inoue, Manami; Kang, Daehee; Luu, Hung N.
Affiliation
  • Paragomi P; Division of Cancer Control and Population Sciences, University of Pittsburgh Medical Center Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
  • Zhang Z; Department of Epidemiology, University of Pittsburgh School of Public Health, Pittsburgh, Pennsylvania.
  • Abe SK; Division of Prevention, National Cancer Center Institute for Cancer Control, Tokyo, Japan.
  • Islam MR; Division of Prevention, National Cancer Center Institute for Cancer Control, Tokyo, Japan.
  • Rahman MS; Department of Global Health Policy, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Saito E; Division of Prevention, National Cancer Center Institute for Cancer Control, Tokyo, Japan.
  • Shu XO; Research Center for Child Mental Development, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Dabo B; Institute for Global Health Policy Research, National Center for Global Health and Medicine, Tokyo, Japan.
  • Pham YT; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Chen Y; Department of Epidemiology and Biostatistics, College of Public Health, University of South Florida, Tampa.
  • Gao YT; Division of Cancer Control and Population Sciences, University of Pittsburgh Medical Center Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
  • Koh WP; Department of Epidemiology, University of Pittsburgh School of Public Health, Pittsburgh, Pennsylvania.
  • Sawada N; Department of Population Health, New York University Grossman School of Medicine, New York.
  • Malekzadeh R; Division of Environmental Medicine, New York University Grossman School of Medicine, New York.
  • Sakata R; Department of Epidemiology, Shanghai Cancer Institute, Shanghai, China.
  • Hozawa A; Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Kim J; Healthy Longevity Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  • Kanemura S; Singapore Institute for Clinical Sciences, Agency for Science Technology and Research, Singapore.
  • Nagata C; Division of Cohort Research, National Cancer Center Institute for Cancer Control, Tokyo, Japan.
  • You SL; Digestive Oncology Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Ito H; Radiation Effects Research Foundation, Hiroshima, Japan.
  • Park SK; Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Yuan JM; Graduate School of Science and Policy, National Cancer Center, Gyeonggi-Do, Republic of Korea.
  • Pan WH; Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Wen W; Department of Epidemiology and Preventive Medicine, Gifu University Graduate School of Medicine, Gifu, Japan.
  • Wang R; School of Medicine and Big Data Research Center, Fu Jen Catholic University, New Taipei City, Taiwan.
  • Cai H; Division of Cancer Information and Control, Department of Preventive Medicine, Aichi Cancer Center Research Institute, Nagoya, Japan.
  • Tsugane S; Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Pourshams A; Division of Cancer Control and Population Sciences, University of Pittsburgh Medical Center Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
  • Sugawara Y; Department of Epidemiology, University of Pittsburgh School of Public Health, Pittsburgh, Pennsylvania.
  • Wada K; Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.
  • Chen CJ; Institute of Population Health Sciences, National Health Research Institutes, Miaoli County, Taiwan.
  • Oze I; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Shin A; Division of Cancer Control and Population Sciences, University of Pittsburgh Medical Center Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
  • Ahsan H; Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Boffetta P; Division of Cohort Research, National Cancer Center Institute for Cancer Control, Tokyo, Japan.
  • Chia KS; Digestive Oncology Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Matsuo K; Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Qiao YL; Department of Epidemiology and Preventive Medicine, Gifu University Graduate School of Medicine, Gifu, Japan.
  • Rothman N; Genomics Research Center, Academia Sinica, Taipei, Taiwan.
  • Zheng W; Division of Cancer Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan.
  • Inoue M; Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Kang D; Cancer Research Institute, Seoul National University, Seoul, Republic of Korea.
  • Luu HN; Department of Public Health Sciences, The University of Chicago, Chicago, Illinois.
JAMA Netw Open ; 7(8): e2429494, 2024 Aug 01.
Article in En | MEDLINE | ID: mdl-39196559
ABSTRACT
Importance The global burden of obesity is increasing, as are colorectal cancer (CRC) incidence and mortality.

Objectives:

To assess the association between body mass index (BMI) and risks of incident CRC and CRC-related death in the Asian population. Design, Setting, and

Participants:

This cohort study includes data pooled from 17 prospective cohort studies included in The Asia Cohort Consortium. Cohort enrollment was conducted from January 1, 1984, to December 31, 2002. Median follow-up time was 15.2 years (IQR, 12.1-19.2 years). Data were analyzed from January 15, 2023, through January 15, 2024. Exposure Body mass index, calculated as weight in kilograms divided by height in meters squared. Main Outcomes and

Measures:

The primary outcomes were CRC incidence and CRC-related mortality. The risk of events is reported as adjusted hazard ratios (AHRs) and 95% CIs for incident CRC and death from CRC using the Cox proportional hazards regression model.

Results:

To assess the risk of incident CRC, 619 981 participants (mean [SD] age, 53.8 [10.1] years; 52.0% female; 11 900 diagnosed incident CRC cases) were included in the study, and to assess CRC-related mortality, 650 195 participants (mean [SD] age, 53.5 [10.2] years; 51.9% female; 4550 identified CRC deaths) were included in the study. A positive association between BMI and risk of CRC was observed among participants with a BMI greater than 25.0 to 27.5 (AHR, 1.09 [95% CI, 1.03-1.16]), greater than 27.5 to 30.0 (AHR, 1.19 [95% CI, 1.11-1.29]), and greater than 30.0 (AHR, 1.32 [95% CI, 1.19-1.46]) compared with those with a BMI greater than 23.0 to 25.0 (P < .001 for trend), and BMI was associated with a greater increase in risk for colon cancer than for rectal cancer. A similar association between BMI and CRC-related death risk was observed among participants with a BMI greater than 27.5 (BMI >27.5-30.0 AHR, 1.18 [95% CI, 1.04-1.34]; BMI >30.0 AHR, 1.38 [95% CI, 1.18-1.62]; P < .001 for trend) and was present among men with a BMI greater than 30.0 (AHR, 1.87 [95% CI, 1.49-2.34]; P < .001 for trend) but not among women (P = .15 for trend) (P = .02 for heterogeneity). Conclusions and Relevance In this cohort study that included a pooled analysis of 17 cohort studies comprising participants across Asia, a positive association between BMI and CRC incidence and related mortality was found. The risk was greater among men and participants with colon cancer. These findings may have implications to better understand the burden of obesity on CRC incidence and related deaths in the Asian population.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Body Mass Index Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: JAMA Netw Open Year: 2024 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Body Mass Index Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: JAMA Netw Open Year: 2024 Document type: Article Country of publication: